Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens

Acta Cytologica

Volumn 55, Issue 6, 2011, Pages 576-583

  Smith, G Denice ^a   Zhou, Luming ^a   Rowe, Leslie R ^a   Jarboe, Elke A ^a   Collins, Brian T ^a   Bentz, Joel S ^a   Wittwer, Carl T ^a   Chadwick, Barbara E ^a  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

Allele specific PCR; Aspiration biopsy; BRAF V600E mutation; Competitive probe blocking; Fine needle aspiration; Papillary thyroid carcinoma; Thyroid cancer

Indexed keywords

B RAF KINASE; PARAFFIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; THYROID PAPILLARY CARCINOMA;

EID: 83455246333     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333453     Document Type: Article

References (22)

1. Demay R: The Art and Science of Cytopathology. Chicago, American Society of Clinical Pathology, 1996.
2. Rowe LR, Bentz BG, Bentz JS: Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules. Cytojournal 2006; 3: 10.
3. Rowe LR, Bentz BG, Bentz JS: Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis. J Clin Pathol 2007; 60: 1211-1215. (Pubitemid 350084540)
4. Nikiforov YE: Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 2011; 135: 569-577.
5. Nikiforov YE: Molecular analysis of thyroid tumors. Mod Pathol 2011; 24(suppl 2):S34-S43.
6. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE: BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003; 88: 5399-5404. (Pubitemid 37452745)
7. Wojciechowska K, Lewinski A: BRAF mutations in papillary thyroid carcinoma. Endocr Regul 2006; 40: 129-138. (Pubitemid 46045518)
8. Xing M: Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 2010; 321: 86-93.
9. Ball DW: Selectively targeting mutant BRAF in thyroid cancer. J Clin Endocrinol Metab 2010; 95: 60-61.
10. Ball DW, Jin N, Rosen DM, Dackiw A, Sidransky D, Xing M, Nelkin BD: Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244. J Clin Endocrinol Metab 2007; 92: 4712-4718. (Pubitemid 350223448)
11. Espinosa AV, Porchia L, Ringel MD: Targeting BRAF in thyroid cancer. Br J Cancer 2007; 96: 16-20. (Pubitemid 46094633)
12. Friday BB, Yu C, Dy GK, Smith PD, Wang L, Thibodeau SN, Adjei AA: BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins. Cancer Res 2008; 68: 6145-6153.
13. Ellison G, Donald E, McWalter G, Knight L, Fletcher L, Sherwood J, Cantarini M, Orr M, Speake G: A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples. J Exp Clin Cancer Res 2010; 29: 132.
14. Lee HJ, Choi J, Hwang TS, Shong YK, Hong SJ, Gong G: Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system. Am J Clin Pathol 2010; 133: 802-808.
15. Mancini I, Santucci C, Sestini R, Simi L, Pratesi N, Cianchi F, Valanzano R, Pinzani P, Orlando C: The use of COLD-PCR and highresolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer. J Mol Diagn 2010; 12: 705-711.
16. Stadelmeyer E, Heitzer E, Wolf P, Dandachi N: COLD-HRM PCR versus conventional HRM PCR to detect the BRAF V600E mutation: a real improvement? J Mol Diagn 2011; 13: 243, author reply 244.
17. Zhou L, Palais RA, Smith GD, Anderson D, Rowe LR, Wittwer CT: Enrichment and detection of rare alleles by means of snapback primers and rapid-cycle PCR. Clin Chem 2010; 56: 814-822.
18. Zhou L, Wang Y, Wittwer CT: Rare allele enrichment and detection by allele-specific PCR, competitive probe blocking, and melting analysis. Biotechniques 2011; 50: 311-318.
19. Smith GD, Chadwick BE, Willmore-Payne C, Bentz JS: Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis. J Clin Pathol 2008; 61: 487-493. (Pubitemid 351518232)
20. Boulet GA, Horvath CA, Berghmans S, Moeneclaey LM, Duys IS, Arbyn M, Depuydt CE, Vereecken AJ, Sahebali S, Bogers JJ: Cervical cytology biobanking: quality of DNA from archival cervical pap-stained smears. J Clin Pathol 2008; 61: 637-641. (Pubitemid 351678219)
21. Killian JK, Walker RL, Suuriniemi M, Jones L, Scurci S, Singh P, Cornelison R, Harmon S, Boisvert N, Zhu J, Wang Y, Bilke S, Davis S, Giaccone G, Smith WI Jr, Meltzer PS: Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling. J Mol Diagn 2010; 12: 739-745.
22. Yip L, Nikiforova MN, Carty SE, Yim JH, Stang MT, Tublin MJ, Lebeau SO, Hodak SP, Ogilvie JB, Nikiforov YE: Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 2009; 146: 1215-1223.